Antiviral activities of <i>ACE2</i> and SARS-CoV-2 ASOs in iACE2 cells.
- Yuanyuan Qiao (1883458)
- Jesse W. Wotring (12430900)
- Charles J. Zhang (5698010)
- Xia Jiang (210366)
- Lanbo Xiao (339837)
- Andy Watt (774845)
- Danielle Gattis (14564450)
- Eli Scandalis (14564453)
- Susan Freier (16888)
- Yang Zheng (185762)
- Carla D. Pretto (2723320)
- Stephanie J. Ellison (14564456)
- Eric E. Swayze (22133)
- Shuling Guo (774846)
- Jonathan Z. Sexton (2263105)
- Arul M. Chinnaiyan (59535)
Publication date
February 2023
DOI Publisher
Public Library of Science (PLoS)Abstract
(A) SARS-CoV-2 bioassay of ACE2 ASOs and SARS-CoV-2 Gapmers in iAEC2 cells against B.1.1.7 strain. P values were calculated using two tailed unpaired t test by comparing to control (Ctrl). (B) Schematic illustration of therapeutic potential of ASOs against SARS-CoV-2 infection.</p
Add to ORKG